Impact of rye-based evening meals on cognitive functions, mood and cardiometabolic risk factors: a randomized controlled study in healthy middle-aged subjects

Nutr J. 2018 Nov 6;17(1):102. doi: 10.1186/s12937-018-0412-4.

Abstract

Background: Whole grain (WG) intake is associated with reduced risk of obesity, type 2 diabetes and cardiovascular disease, whereas type 2 diabetes increases the risk of cognitive decline and dementia. The purpose of this study was to investigate the effects of short-term intervention with WG rye on cognitive functions, mood and cardiometabolic risk markers in middle-aged test subjects.

Method: Rye-based breads were provided to 38 healthy test subjects (aged 52-70y) during three consecutive days in a crossover study design, using white wheat flour bread (WWB) as a reference. The rye-based bread consisted of a WG rye kernel/flour mixture (1:1 ratio) supplemented with resistant starch type 2 (RS2) (RB + RS2). The last bread portion was ingested at 2100 h, and cognitive function, mood and cardiometabolic risk markers were determined the following morning, 11 - 14 h post intake.

Results: In comparison to WWB, the RB + RS2 product increased ratings of mood parameters (valance, P < 0.001; activation P < 0.05). No differences were seen in the cognitive tests depending on intervention (P > 0.05). RB + RS2 increased insulin sensitivity (P < 0.05), fasting levels of gut hormones (PYY, P < 0.05; GLP-2, P < 0.01) and fasting concentrations of plasma acetate, butyrate and total SCFA (P < 0.001). In contrast, fasting levels of IL - 1β were decreased (P < 0.05). Insulin sensitivity was positively correlated with working memory test performance (P < 0.05).

Conclusions: This study display novel findings regarding effects of WG rye products on mood, and glucose and appetite regulation in middle-aged subjects, indicating anti-diabetic properties of WG rye. The beneficial effects are suggested to be mediated through gut fermentation of dietary fiber in the RB + RS2 product.

Trial registration: The study was retrospectively registered at ClinicalTrials.gov, register number NCT03275948 . Registered September 8 2017.

Keywords: Cognition; Dietary fiber; Dietary prevention; Glucose regulation; Gut fermentation; Gut hormones; Mood; Obesity; Type 2 diabetes; Whole grain rye.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetates / blood
  • Affect / physiology*
  • Aged
  • Biomarkers / blood
  • Blood Glucose*
  • Butyrates / blood
  • Cognition / physiology*
  • Cross-Over Studies
  • Diet / methods*
  • Fatty Acids / blood*
  • Feeding Behavior / physiology
  • Female
  • Gastrointestinal Hormones / blood
  • Humans
  • Insulin Resistance
  • Male
  • Meals / physiology*
  • Middle Aged
  • Retrospective Studies
  • Triticale*

Substances

  • Acetates
  • Biomarkers
  • Blood Glucose
  • Butyrates
  • Fatty Acids
  • Gastrointestinal Hormones

Associated data

  • ClinicalTrials.gov/NCT03275948